Found 7 matching trials
SGT-53, Carboplatin, and Pembrolizumab for the Treatment of Metastatic Triple Negative Inflammatory Breast Cancer
PHASE1This phase I trial studies the effect of SGT-53, carboplatin, and pembroliz...
Location
Northwestern University
A Phase 0/1 Study of cDNA for TP53, Checkpoint Inhibition and Radiation in Children With Recurrent, Progressive or Refractory CNS Malignancies.
EARLY_PHASE1This clinical trial is studying a drug called SGT-53 along with radiation a...
Location
Children's National Hospital
SGT-53 in Children With Recurrent or Progressive CNS Malignancies
EARLY_PHASE1An early phase 1 for pediatric patients with recurrent or progressive CNS m...
Location
Children's National Medical Center
A Study of SGT-53 in Children With Refractory or Recurrent Solid Tumors
PHASE1The purpose of this study is to determine the dose limiting toxicities and ...
Location
Texas Children's Hospital
Safety Study of Infusion of SGT-53 to Treat Solid Tumors
PHASE1This is a Phase Ib study as a continuation of the original Phase I protocol...
Location
Mary Crowley Medical Research Center
Study of Combined SGT-53 Plus Gemcitabine/Nab-Paclitaxel for Metastatic Pancreatic Cancer
PHASE2This clinical trial is an open label Phase II study of the combination of i...
Status
Active Not Recruiting
Location
Mary Crowley Cancer Research Center
Phase II Study of Combined Temozolomide and SGT-53 for Treatment of Recurrent Glioblastoma
PHASE2This Phase II clinical trial is an open label, single arm, multicenter stud...
Location
MD Anderson Cancer Center